An observational study in Intracranial Hemorrhages, sponsored by Uppsala University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-09-19.
Sponsored by Uppsala University · Observational
The goal of this observational study is to learn about the influence of extracellular water on volume status in adult patients with intracranial hemorrhage presenting with hemodynamic instability. The main question it aims to answer is:
Adult patients with intracranial hemorrhage admitted to ICU will be recruited. During the first five days after inclusion blood samples and extended non-invasive monitoring, including monitoring of the microcirculation (CytoCam) and measurement of extracellular water (dielectronic constant), will be added to routine care and monitoring.
204 studies on the registry are indexed under Intracranial Hemorrhages; 66 are open to participants now.
This study's planned enrollment of 10 is below the median of 236 across 89 observational studies indexed under Intracranial Hemorrhages.
Browse Intracranial Hemorrhages studies →Uppsala University is the lead sponsor of 390 studies on the registry; 86 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Adult patients admitted to ICU in Uppsala with intracranial hemorrhage.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Extracellular water for volume status characterization in patients with intracranial hemorrhage.
Can measurement of extracellular water (MoistureMeterD, Delfin Technologies Ltd, Kuopio, Finland) contribute to the description of hemodynamic instability in adult patients with intracranial hemorrhage during the first five days?
Time frame: 7 days
No study locations are listed for this record.
Plan to share: No — The data will only be accessible to the research team.
Start is estimated for Sep 2024; primary completion for Sep 2026, 24 months later.
Of 43 observational studies under Intracranial Hemorrhages, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 103. This study's planned 24 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.